All Stories

  1. Crystal structure of glycerol kinase from Trypanosoma cruzi, a potential molecular target in Chagas disease
  2. Crystal Structure of Staphopain C from Staphylococcus aureus
  3. Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe
  4. DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin Homeostasis
  5. Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis
  6. Structure, Biosynthesis, and Biological Activity of Succinylated Forms of Bacteriocin BacSp222
  7. Distinct sequence and structural feature of trypanosoma malate dehydrogenase
  8. Ultrasensitive electrochemical determination of the cancer biomarker protein sPD-L1 based on a BMS-8-modified gold electrode
  9. Structural Determinants of Substrate Specificity of SplF Protease from Staphylococcus aureus
  10. Isolation, Identification, and Bioinformatic Analysis of Antibacterial Proteins and Peptides from Immunized Hemolymph of Red Palm Weevil Rhynchophorus ferrugineus
  11. Structural Characterization of Glycerol Kinase from the Thermophilic Fungus Chaetomium thermophilum
  12. Macrocyclic Peptide Inhibitor of PD‐1/PD‐L1 Immune Checkpoint
  13. Chromosomal localization of PemIK toxin-antitoxin system results in the loss of toxicity – Characterization of pemIK-Sp from Staphylococcus pseudintermedius
  14. Crystal Structure of Mannose Specific IIA Subunit of Phosphotransferase System from Streptococcus pneumoniae
  15. Anti-CD44 DNA Aptamers Selectively Target Cancer Cells
  16. A real‐time cell‐binding assay reveals dynamic features of STxB–Gb3 cointernalization and STxB‐mediated cargo delivery into cancer cells
  17. Kallikrein-Related Peptidase 14 Activates Zymogens of Membrane Type Matrix Metalloproteinases (MT-MMPs)—A CleavEx Based Analysis
  18. Water envelope has a critical impact on the design of protein–protein interaction inhibitors
  19. Structure–Activity Relationship in Pyrazolo[4,3-c]pyridines, First Inhibitors of PEX14–PEX5 Protein–Protein Interaction with Trypanocidal Activity
  20. Photoinactivation of microorganisms with sub-micromolar concentrations of imidazolium metallophthalocyanine salts
  21. Surface Modification of Nanocrystalline TiO2 Materials with Sulfonated Porphyrins for Visible Light Antimicrobial Therapy
  22. Crystal Structure of Kluyveromyces lactis Glucokinase (KlGlk1)
  23. Sensitization of TiO2 by halogenated porphyrin derivatives for visible light biomedical and environmental photocatalysis
  24. Production of Lysostaphin by Nonproprietary Method Utilizing a Promoter from Toxin–Antitoxin System
  25. Crystal structure of Maternal Embryonic Leucine Zipper Kinase (MELK) in complex with dorsomorphin (Compound C)
  26. Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment
  27. Development of Chemical Tools to Monitor Human Kallikrein 13 (KLK13) Activity
  28. A fluorinated indole‐based MDM 2 antagonist selectively inhibits the growth of p53 wt osteosarcoma cells
  29. Development of a novel, high-affinity ssDNA trypsin inhibitor
  30. Joint Genomic and Proteomic Analysis Identifies Meta-Trait Characteristics of Virulent and Non-virulent Staphylococcus aureus Strains
  31. Crystal structure of the FAS1 domain of the hyaluronic acid receptor stabilin-2
  32. Structural basis for ADP-dependent glucokinase inhibition by 8-bromo–substituted adenosine nucleotide
  33. Identification of small-molecule inhibitors of USP2a
  34. Unique Substrate Specificity of SplE Serine Protease from Staphylococcus aureus
  35. A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia
  36. Crystal structure of ADP-dependent glucokinase from Methanocaldococcus jannaschii in complex with 5-iodotubercidin reveals phosphoryl transfer mechanism
  37. Spatial attributes of the four-helix bundle group of bacteriocins – The high-resolution structure of BacSp222 in solution
  38. Modular endolysin of Burkholderia AP3 phage has the largest lysozyme-like catalytic subunit discovered to date and no catalytic aspartate residue
  39. Identification of novel mazEF/pemIK family toxin-antitoxin loci and their distribution in the Staphylococcus genus
  40. Structural analysis of PIM1 kinase complexes with ATP-competitive inhibitors
  41. Staphylococcus Aureus V8 protease disrupts the integrity of the airway epithelial barrier and impairs IL-6 production in vitro
  42. Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies
  43. Bioactive Macrocyclic Inhibitors of the PD-1/PD-L1 Immune Checkpoint
  44. Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells
  45. Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
  46. Crystal structure of a low molecular weight activator Blm-pep with yeast 20S proteasome – insights into the enzyme activation mechanism
  47. Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1
  48. Malassezia globosa Mg MDL2 lipase: Crystal structure and rational modification of substrate specificity
  49. 1,4,5-Trisubstituted Imidazole-Based p53–MDM2/MDMX Antagonists with Aliphatic Linkers for Conjugation with Biological Carriers
  50. Lithocholic Acid Hydroxyamide Destabilizes Cyclin D1 and Induces G 0 /G 1 Arrest by Inhibiting Deubiquitinase USP2a
  51. Structural Characterization of Human Coronavirus NL63 N Protein
  52. Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interaction
  53. A Unique Mdm2-Binding Mode of the 3-Pyrrolin-2-one- and 2-Furanone-Based Antagonists of the p53-Mdm2 Interaction
  54. Distinct 3D Architecture and Dynamics of the Human HtrA2(Omi) Protease and Its Mutated Variants
  55. Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)
  56. Visualization of kallikreins in thyroid epithelial and carcinoma cells
  57. Identification of Secreted Exoproteome Fingerprints of Highly-Virulent and Non-Virulent Staphylococcus aureus Strains
  58. Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor
  59. Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor
  60. Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1)
  61. The outer-membrane export signal of Porphyromonas gingivalis type IX secretion system (T9SS) is a conserved C-terminal β-sandwich domain
  62. Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
  63. PD-1 binding domain from human PD-L1
  64. Structure of the complex of human programmed death-1 (PD-1) and its ligand PD-L1.
  65. Investigation of Serine-Proteinase-Catalyzed Peptide Splicing in Analogues of Sunflower Trypsin Inhibitor 1 (SFTI-1)
  66. Structural Basis of GD2 Ganglioside and Mimetic Peptide Recognition by 14G2a Antibody
  67. The Nucleocapsid Protein of Human Coronavirus NL63
  68. Atomic resolution crystal structure of HV-BBI protease inhibitor from amphibian skin in complex with bovine trypsin
  69. A systematic investigation of the stability of green fluorescent protein fusion proteins
  70. Staphylococcal SplB Serine Protease Utilizes a Novel Molecular Mechanism of Activation
  71. Staphylococcal Proteases Aid in Evasion of the Human Complement System
  72. Development and binding characteristics of phosphonate inhibitors of SplA protease from Staphylococcus aureus
  73. Biochemical and Structural Characterization of SplD Protease from Staphylococcus aureus
  74. A regulatory role for Staphylococcus aureus toxin–antitoxin system PemIKSa
  75. Structural phase transition and related electronic properties in quasi-one-dimensional (NbSe4)10/3I
  76. Insights into eukaryotic Rubisco assembly — Crystal structures of RbcX chaperones from Arabidopsis thaliana
  77. Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011 – present)
  78. Bacterial Proteases in Disease – Role in Intracellular Survival, Evasion of Coagulation/ Fibrinolysis Innate Defenses, Toxicoses and Viral Infections
  79. Bacterial Proteases in Disease – Role in Intracellular Survival, Evasion of Coagulation/ Fibrinolysis Innate Defenses, Toxicoses and Viral Infections
  80. Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91
  81. Staphylococcal proteases aid evasion of human complement system
  82. Prevalence of genes encoding extracellular proteases inStaphylococcus aureus— important targets triggering immune responsein vivo
  83. The virulence of Staphylococcus aureus correlates with strain genotype in a chicken embryo model but not a nematode model
  84. The development of first Staphylococcus aureus SplB protease inhibitors: Phosphonic analogues of glutamine
  85. On the Mechanism of Action of SJ-172550 in Inhibiting the Interaction of MDM4 and p53
  86. Substrate specificity of Staphylococcus aureus cysteine proteases – Staphopains A, B and C
  87. α1-Antichymotrypsin inactivates staphylococcal cysteine protease in cross-class inhibition
  88. Activation mechanism of thiol protease precursor from broiler chicken specific Staphylococcus aureus strain CH-91
  89. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73
  90. Exfoliative Toxins of Staphylococcus aureus
  91. A novel matrix metalloprotease-like enzyme (karilysin) of the periodontal pathogen Tannerella forsythia ATCC 43037
  92. Structural and functional characterization of SplA, an exclusively specific protease of Staphylococcus aureus
  93. High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx
  94. Elafin is specifically inactivated by RgpB from Porphyromonas gingivalis by distinct proteolytic cleavage
  95. Enzymatic Activity of the Staphylococcus aureus SplB Serine Protease is Induced by Substrates Containing the Sequence Trp-Glu-Leu-Gln
  96. Staphylococcus aureusinfection triggers production of neutralizing, V8 protease-specific antibodies
  97. The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin
  98. Staphylococcus aureus-Derived Staphopain B, a Potent Cysteine Protease Activator of Plasma Chemerin
  99. The staphostatin family of cysteine protease inhibitors in the genus Staphylococcus as an example of parallel evolution of protease and inhibitor specificity
  100. Functional and Structural Characterization of Spl Proteases from Staphylococcus aureus
  101. Proteinaceous cysteine protease inhibitors
  102. Letter to the Editor: 1 H, 15 N and 13 C NMR Resonance Assignments of Staphostatin A, a Specific Staphylococcus Aureus Cysteine Proteinase Inhibitor
  103. Characterisation of a highly specific, endogenous inhibitor of cysteine protease from Staphylococcus epidermidis, a new member of the staphostatin family
  104. A Novel Class of Cysteine Protease Inhibitors:  Solution Structure of Staphostatin A fromStaphylococcus aureus†
  105. Extracellular Proteases of Staphylococcus spp.
  106. Molecular Cloning and Biochemical Characterisation of Proteases from Staphylococcus epidermidis